Evaluation of Second Solid Cancers After Hematopoietic Stem Cell Transplantation in European Patients.

ABSTRACT:

Importance

Incidence and risk factors of second solid cancers (SSCs) that occur after hematopoietic stem cell transplantation (HSCT) are well documented. However, clinical outcome data of patients who developed an SSC after HSCT are limited.

Objective

To assess the outcome of patients with an SSC occurring after HSCT from the time of SSC diagnosis.

Design, setting, and participants

This cohort study used data of 4065 patients from 26 countries registered with the European Society for Blood and Marrow Transplantation, which has maintained clinical data since 1977 of patients who received a transplant. Information from all patients who underwent a transplant in Europe and had an SSC diagnosis between January 1, 2000, and December 31, 2014, was extracted. The cohort incl

SUBMITTER: Tichelli A 

PROVIDER: S-EPMC6439555 | biostudies-literature | 2019 Feb

REPOSITORIES: biostudies-literature